The Canadian Cancer Society (CCS) and the Creative Destruction Lab (CDL) have launched a new world-class accelerator program for entrepreneurs and researchers developing innovations to improve the cancer experience globally and throughout the cancer care continuum. This program will educate, coach, finance and inspire seed-stage oncology-focused companies by pairing them with mentors, industry leaders and subject matter experts. Over 9 months and 5 sessions, accepted startups will be supporte... Read More »
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2019. A grand total of $7.4 billion was invested during this 15-year period. The fluctuating investment in major infrastructure drove peaks and valleys in the overall investmen... Read More »